| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2435005
Max Phase: Preclinical
Molecular Formula: C19H15BrN4O
Molecular Weight: 395.26
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CN(C)c1cc[n+]([C-](C=C(C#N)C#N)C(=O)c2ccc(Br)cc2)cc1
Standard InChI: InChI=1S/C19H15BrN4O/c1-23(2)17-7-9-24(10-8-17)18(11-14(12-21)13-22)19(25)15-3-5-16(20)6-4-15/h3-11H,1-2H3
Standard InChI Key: FXAFWMGCEFEFJL-UHFFFAOYSA-N
Associated Targets(Human)
Protein farnesyltransferase 3470 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 395.26 | Molecular Weight (Monoisotopic): 394.0429 | AlogP: 3.04 | #Rotatable Bonds: 5 |
| Polar Surface Area: 71.77 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.82 | CX Basic pKa: | CX LogP: -0.67 | CX LogD: -0.67 |
| Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.34 | Np Likeness Score: -0.74 |
References
| 1. Abuhaie CM, Ghinet A, Farce A, Dubois J, Rigo B, Bîcu E.. (2013) Synthesis and biological evaluation of a new series of N-ylides as protein farnesyltransferase inhibitors., 23 (21): [PMID:24054122] [10.1016/j.bmcl.2013.08.088] |
Source
Source(1):